NO20090289L - Inhibitorer av akt (proteinkinase B) - Google Patents

Inhibitorer av akt (proteinkinase B)

Info

Publication number
NO20090289L
NO20090289L NO20090289A NO20090289A NO20090289L NO 20090289 L NO20090289 L NO 20090289L NO 20090289 A NO20090289 A NO 20090289A NO 20090289 A NO20090289 A NO 20090289A NO 20090289 L NO20090289 L NO 20090289L
Authority
NO
Norway
Prior art keywords
protein kinase
act inhibitors
inhibitors
act
compounds
Prior art date
Application number
NO20090289A
Other languages
English (en)
Norwegian (no)
Inventor
Christopher Randall Schmid
Michael R Myers
Renhua Li
Sajan Joseph
Aktham Aburub
Jenny Pingqi Dai
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20090289L publication Critical patent/NO20090289L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20090289A 2006-06-20 2009-01-19 Inhibitorer av akt (proteinkinase B) NO20090289L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80526006P 2006-06-20 2006-06-20
US88576507P 2007-01-19 2007-01-19
PCT/US2007/070945 WO2007149730A2 (en) 2006-06-20 2007-06-12 Inhibitors of akt (protein kinase b)

Publications (1)

Publication Number Publication Date
NO20090289L true NO20090289L (no) 2009-01-19

Family

ID=38834248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090289A NO20090289L (no) 2006-06-20 2009-01-19 Inhibitorer av akt (proteinkinase B)

Country Status (28)

Country Link
US (1) US7998977B2 (de)
EP (1) EP2035385B1 (de)
JP (1) JP2009541335A (de)
KR (1) KR101067551B1 (de)
AR (1) AR061240A1 (de)
AT (1) ATE455102T1 (de)
AU (1) AU2007261120A1 (de)
BR (1) BRPI0713136A2 (de)
CA (1) CA2652612A1 (de)
CL (1) CL2007001752A1 (de)
DE (1) DE602007004333D1 (de)
DK (1) DK2035385T3 (de)
DO (1) DOP2008000053A (de)
EA (1) EA015712B1 (de)
EC (1) ECSP088992A (de)
ES (1) ES2336630T3 (de)
HR (1) HRP20100147T1 (de)
IL (1) IL195005A0 (de)
MA (1) MA30757B1 (de)
MX (1) MX2008015904A (de)
NO (1) NO20090289L (de)
PE (1) PE20080338A1 (de)
PL (1) PL2035385T3 (de)
PT (1) PT2035385E (de)
SI (1) SI2035385T1 (de)
TN (1) TNSN08529A1 (de)
TW (1) TW200812970A (de)
WO (1) WO2007149730A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
EP2766029B1 (de) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Behandlung degenerativer gelenkerkrankungen
CA2846394A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
CA2928568A1 (en) 2013-07-26 2015-01-29 Update Pharma Inc. Combinatorial methods to improve the therapeutic benefit of bisantrene
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US10123997B2 (en) * 2015-06-15 2018-11-13 Yong Liao Target for treating hepatitis B virus
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
CA3186565A1 (en) * 2020-07-22 2022-01-27 Lei Miao Unit dosage composition of akt inhibitor
US20230271958A1 (en) * 2020-07-22 2023-08-31 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136458A0 (en) 2000-05-30 2001-06-14 Peptor Ltd Protein kinase inhibitors
CN1768040A (zh) * 2003-03-28 2006-05-03 伊莱利利公司 作为akt(蛋白激酶b)抑制剂的异喹啉－5－磺酸酰胺
GB0317315D0 (en) 2003-07-24 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
WO2005054202A1 (en) 2003-11-25 2005-06-16 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)

Also Published As

Publication number Publication date
TW200812970A (en) 2008-03-16
US20090221633A1 (en) 2009-09-03
JP2009541335A (ja) 2009-11-26
MX2008015904A (es) 2009-01-12
EP2035385A2 (de) 2009-03-18
HRP20100147T1 (hr) 2010-04-30
MA30757B1 (fr) 2009-10-01
SI2035385T1 (sl) 2010-05-31
US7998977B2 (en) 2011-08-16
CL2007001752A1 (es) 2008-01-18
ECSP088992A (es) 2009-01-30
KR20090015978A (ko) 2009-02-12
WO2007149730A3 (en) 2008-04-24
DOP2008000053A (es) 2009-01-15
BRPI0713136A2 (pt) 2012-04-17
AR061240A1 (es) 2008-08-13
PL2035385T3 (pl) 2010-06-30
KR101067551B1 (ko) 2011-09-27
ATE455102T1 (de) 2010-01-15
PE20080338A1 (es) 2008-04-25
PT2035385E (pt) 2010-03-01
ES2336630T3 (es) 2010-04-14
DK2035385T3 (da) 2010-03-22
EP2035385B1 (de) 2010-01-13
TNSN08529A1 (en) 2010-04-14
CA2652612A1 (en) 2007-12-27
AU2007261120A1 (en) 2007-12-27
DE602007004333D1 (de) 2010-03-04
EA015712B1 (ru) 2011-10-31
IL195005A0 (en) 2009-08-03
WO2007149730A2 (en) 2007-12-27
EA200970041A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
TNSN08529A1 (en) Inhibitors of akt (protein kinase b)
NO2020010I1 (no) fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat
NO20081569L (no) Administrasjon av dipeptidylpeptildaseinhibitorer
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
DK1658292T3 (da) Triazologyrimidinderivater som glycogensynthasekinase 3 - inhibitorer
SE0400284D0 (sv) Novel compounds
EA200900135A1 (ru) Производные пиразола в качестве ингибиторов цитохрома р450
DK1711481T4 (da) Krystallinsk monohydrat som kinaseinhibitorer
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
UY30298A1 (es) Inhibidores de la quinasa c-fms ii
NO20082482L (no) Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
NO20083918L (no) Dihydridiazepiner anvendelige som inhibitorer av proteinkinaser
NO20052888D0 (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
MX2009011579A (es) Pirimidinonas como moduladores de caseina cinasa ii (ck2).
AR062745A1 (es) 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol como inhibidor de quinasa
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
DE602005023333D1 (de) Kinaseinhibitoren
EA200870448A1 (ru) Тризамещенные 1,2,4-триазолы
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
NO20080484L (no) Niacin-reseptorantagonister, preparater inneholdende slike forbindelser og behandlingsmetoder
NO20085099L (no) Puritonderivativer som HM74A agonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application